Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients.


Journal

Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900

Informations de publication

Date de publication:
28 Mar 2022
Historique:
received: 29 07 2021
accepted: 19 11 2021
pubmed: 15 12 2021
medline: 5 4 2022
entrez: 14 12 2021
Statut: epublish

Résumé

Classical homocystinuria (HCU) is an autosomal recessive inborn error of metabolism, which is caused by the cystathionine-β-synthase (CBS: encoded by A total of 429 ID patients (age range: 1.6-23 years) were sampled from Northern areas of Punjab, Pakistan. Biochemical and genetic analyses were performed to find classical HCU disease in ID patients. Biochemically, nine patients from seven unrelated families were identified with high levels of plasma methionine and homocysteine. Targeted exonic analysis of With personalized treatment and care, such patients can reach their full potential of living as healthy a life as possible. This screening study is one of the pioneering initiatives in Pakistan which would help to minimize the burden of such treatable inborn errors of metabolism in the intellectually disabled patients.

Sections du résumé

BACKGROUND BACKGROUND
Classical homocystinuria (HCU) is an autosomal recessive inborn error of metabolism, which is caused by the cystathionine-β-synthase (CBS: encoded by
METHODS METHODS
A total of 429 ID patients (age range: 1.6-23 years) were sampled from Northern areas of Punjab, Pakistan. Biochemical and genetic analyses were performed to find classical HCU disease in ID patients.
RESULTS RESULTS
Biochemically, nine patients from seven unrelated families were identified with high levels of plasma methionine and homocysteine. Targeted exonic analysis of
CONCLUSIONS CONCLUSIONS
With personalized treatment and care, such patients can reach their full potential of living as healthy a life as possible. This screening study is one of the pioneering initiatives in Pakistan which would help to minimize the burden of such treatable inborn errors of metabolism in the intellectually disabled patients.

Identifiants

pubmed: 34905667
pii: jpem-2021-0508
doi: 10.1515/jpem-2021-0508
doi:

Substances chimiques

Cystathionine beta-Synthase EC 4.2.1.22

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-332

Informations de copyright

© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Références

van Karnebeek, CDM. Evaluation of the child with developmental impairments. Continuum (Minneap Minn) 2018;24:228–47. https://doi.org/10.1212/con.0000000000000564.
Graham, E, Lee, J, Price, M, Tarailo-Graovac, M, Matthews, A, Engelke, U, et al.. Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review. J Inherit Metab Dis 2018;41:435–45. https://doi.org/10.1007/s10545-018-0139-6.
Ferreira, CR, van Karnebeek, CDM, Vockley, J, Blau, N. A proposed nosology of inborn errors of metabolism. Genet Med 2019;21:102–6. https://doi.org/10.1038/s41436-018-0022-8.
Ibarra-Gonzalez, I, Rodriguez-Valentin, R, Lazcano-Ponce, E, Vela-Amieva, M. Metabolic screening and metabolomics analysis in the intellectual developmental disorders Mexico study. Salud Publica Mex 2017;59:423–8. https://doi.org/10.21149/8668.
Colonetti, K, Roesch, LF, Schwartz, IVD. The microbiome and inborn errors of metabolism: why we should look carefully at their interplay? Genet Mol Biol 2018;41:515–32. https://doi.org/10.1590/1678-4685-gmb-2017-0235.
Voskoboeva, E, Semyachkina, A, Yablonskaya, M, Nikolaeva, E. Homocystinuria due to cystathionine beta-synthase (CBS) deficiency in Russia: molecular and clinical characterization. Mol Genet Metab Rep 2018;14:47–54. https://doi.org/10.1016/j.ymgmr.2017.11.001.
Li, DX, Li, XY, Dong, H, Liu, YP, Ding, Y, Song, JQ, et al.. Eight novel mutations of CBS gene in nine Chinese patients with classical homocystinuria. World J Pediatr 2018;14:197–203. https://doi.org/10.1007/s12519-018-0135-9.
Mudd, SH, Skovby, F, Levy, HL, Pettigrew, KD, Wilcken, B, Pyeritz, RE, et al.. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1–31.
Poloni, S, Sperb-Ludwig, F, Borsatto, T, Weber Hoss, G, Doriqui, MJR, Embirucu, EK, et al.. CBS mutations are good predictors for B6-responsiveness: a study based on the analysis of 35 Brazilian Classical Homocystinuria patients. Mol Genet Genomic Med 2018;6:160–70. https://doi.org/10.1002/mgg3.342.
Huemer, M, Kozich, V, Rinaldo, P, Baumgartner, MR, Merinero, B, Pasquini, E, et al.. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. J Inherit Metab Dis 2015;38:1007–19. https://doi.org/10.1007/s10545-015-9830-z.
Vanzin, CS, Mescka, CP, Donida, B, Hammerschimidt, TG, Ribas, GS, Kolling, J, et al.. Lipid, oxidative and inflammatory profile and alterations in the enzymes paraoxonase and butyrylcholinesterase in plasma of patients with homocystinuria due CBS deficiency: the vitamin B12 and folic acid importance. Cell Mol Neurobiol 2015;35:899–911. https://doi.org/10.1007/s10571-015-0185-7.
Maclean, KN, Jiang, H, Greiner, LS, Allen, RH, Stabler, SP. Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk. Mol Genet Metabol 2012;105:395–403. https://doi.org/10.1016/j.ymgme.2011.11.190.
Lee, PJ, Briddon, A. A rationale for cystine supplementation in severe homocystinuria. J Inherit Metab Dis 2007;30:35–8. https://doi.org/10.1007/s10545-006-0452-3.
El Bashir, H, Dekair, L, Mahmoud, Y, Ben-Omran, T. Neurodevelopmental and cognitive outcomes of classical homocystinuria: experience from Qatar. JIMD Rep 2015;21:89–95. https://doi.org/10.1007/8904_2014_394.
Morris, AA, Kozich, V, Santra, S, Andria, G, Ben-Omran, TI, Chakrapani, AB, et al.. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis 2017;40:49–74. https://doi.org/10.1007/s10545-016-9979-0.
Bublil, EM, Majtan, T. Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies. Biochimie 2020;173:48–56. https://doi.org/10.1016/j.biochi.2019.12.007.
Majtan, T, Park, I, Cox, A, Branchford, BR, di Paola, J, Bublil, EM, et al.. Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy. FASEB J 2019;33:12477–86. https://doi.org/10.1096/fj.201901203r.
Majtan, T, Jones, WJr, Krijt, J, Park, I, Kruger, WD, Kožich, V, et al.. Enzyme replacement therapy ameliorates multiple symptoms of murine homocystinuria. Mol Ther 2018;26:834–44. https://doi.org/10.1016/j.ymthe.2017.12.014.
Majtan, T, Hůlková, H, Park, I, Krijt, J, Kožich, V, Bublil, EM, et al.. Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria. FASEB J 2017;31:5495–506. https://doi.org/10.1096/fj.201700565r.
Munke, M, Kraus, JP, Ohura, T, Francke, U. The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. Am J Hum Genet 1988;42:550–9.
Silao, CL, Fabella, TD, Rama, KI, Estrada, SC. Novel cystathionine beta-synthase gene mutations in a Filipino patient with classic homocystinuria. Pediatr Int 2015;57:884–7. https://doi.org/10.1111/ped.12666.
Skovby, F, Gaustadnes, M, Mudd, SH. A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metabol 2010;99:1–3. https://doi.org/10.1016/j.ymgme.2009.09.009.
Moorthie, S, Cameron, L, Sagoo, GS, Bonham, JR, Burton, H. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis 2014;37:889–98. https://doi.org/10.1007/s10545-014-9729-0.
Ullah, MA, Husseni, AM, Mahmood, SU. Consanguineous marriages and their detrimental outcomes in Pakistan: an urgent need for appropriate measures. Int J Community Med Public Health 2017;5:3. https://doi.org/10.18203/2394-6040.ijcmph20175757.
Wasim, M, Khan, HN, Ayesha, H, Goorden, SMI, Vaz, FM, van Karnebeek, CDM, et al.. Biochemical screening of intellectually disabled patients: a stepping stone to initiate a newborn screening program in Pakistan. Front Neurol 2019;10. https://doi.org/10.3389/fneur.2019.00762.
Modi, BP, Khan, HN, van der Lee, R, Wasim, M, Haaxma, CA, Richmond, PA, et al.. Adult GAMT deficiency: a literature review and report of two siblings. Mol Genet Metabol Rep 2021;27:100761. https://doi.org/10.1016/j.ymgmr.2021.100761.
Ibrahim, S, Maqbool, S, Azam, M, Iqbal, MP, Qamar, R. CBS mutations and MTFHR SNPs causative of hyperhomocysteinemia in Pakistani children. Mol Biol Rep 2018;45:353–60. https://doi.org/10.1007/s11033-018-4169-9.
Lee, SJ, Lee, DH, Yoo, HW, Koo, SK, Park, ES, Park, JW, et al.. Identification and functional analysis of cystathionine beta-synthase gene mutations in patients with homocystinuria. J Hum Genet 2005;50:648–54. https://doi.org/10.1007/s10038-005-0312-2.
Linnebank, M, Janosik, M, Kozich, V, Pronicka, E, Kubalska, J, Sokolova, J, et al.. The cystathionine beta-synthase (CBS) mutation c.1224-2A>C in Central Europe: vitamin B6 nonresponsiveness and a common ancestral haplotype. Hum Mutat 2004;24:352–3. https://doi.org/10.1002/humu.9280.

Auteurs

Muhammad Wasim (M)

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
NIBGE-College, Pakistan Institute of Engineering and Applied Sciences (PIEAS), Nilore, Islamabad, Pakistan.

Haq N Khan (HN)

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
NIBGE-College, Pakistan Institute of Engineering and Applied Sciences (PIEAS), Nilore, Islamabad, Pakistan.
Department of Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan.

Hina Ayesha (H)

Department of Pediatrics, Allied & DHQ Hospitals, Faisalabad Medical University (FMU/PMC), Faisalabad, Pakistan.

Mazhar Iqbal (M)

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
NIBGE-College, Pakistan Institute of Engineering and Applied Sciences (PIEAS), Nilore, Islamabad, Pakistan.

Abdul Tawab (A)

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
NIBGE-College, Pakistan Institute of Engineering and Applied Sciences (PIEAS), Nilore, Islamabad, Pakistan.

Muhammad Irfan (M)

Department of Pediatrics, Allied & DHQ Hospitals, Faisalabad Medical University (FMU/PMC), Faisalabad, Pakistan.

Warsha Kanhai (W)

Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Duivendrecht, The Netherlands.

Susanna M I Goorden (SMI)

Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Duivendrecht, The Netherlands.

Lida Stroomer (L)

Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Duivendrecht, The Netherlands.

Gajja Salomons (G)

Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Duivendrecht, The Netherlands.

Frederic M Vaz (FM)

Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers, Duivendrecht, The Netherlands.
Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Clara D M van Karnebeek (CDMV)

Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Fazli R Awan (FR)

Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Pakistan.
NIBGE-College, Pakistan Institute of Engineering and Applied Sciences (PIEAS), Nilore, Islamabad, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH